Tiziana Life Sciences Ltd TLSA Stock Analysis
- Nasdaq
- Stock
- Market open · no trades yet today
$0.62 down $0.02, 2.76% at close Nov 5
Last close · Previous close $0.64
- 52-week change
- Price only
- Distributions
- Per share, last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$0.62down $0.02, 2.76%Thu, Nov 5 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$0.64Nov 4
- Volume766.17KNov 5 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume667.70KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $0.57 to $1.90; now $0.62
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 5 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
TLSA trailed the S&P 500 in all 6 periods.
| Period | TLSA and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | TLSA: down 42.0% S&P 500: down 5.4% | TLSA trailed the S&P 500 by 36.6 percentage points Trailed |
| 3M | TLSA: down 37.3% S&P 500: down 4.5% | TLSA trailed the S&P 500 by 32.8 percentage points Trailed |
| YTD | TLSA: down 58.4% S&P 500: up 8.3% | TLSA trailed the S&P 500 by 66.7 percentage points Trailed |
| 1Y | TLSA: down 66.3% S&P 500: up 9.3% | TLSA trailed the S&P 500 by 75.6 percentage points Trailed |
| Long term | ||
| 3Y | TLSA: down 5.6% S&P 500: up 74.8% −1.9% vs +20.5% a year | TLSA trailed the S&P 500 by 80.4 percentage points Trailed |
| 5Y | TLSA: down 59.7% S&P 500: up 67.3% −16.6% vs +10.8% a year | TLSA trailed the S&P 500 by 127.0 percentage points Trailed |
$10,000 invested in TLSA 5 years ago (Nov 5, 2021) would be worth about $4,029 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $16,730.
TLSA trailed the S&P 500 in all 6 periods.
| Period | TLSA and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | TLSA: down 42.0% S&P 500: down 5.4% | TLSA trailed the S&P 500 by 36.6 percentage points Trailed |
| 3M | TLSA: down 37.3% S&P 500: down 4.8% | TLSA trailed the S&P 500 by 32.5 percentage points Trailed |
| YTD | TLSA: down 58.4% S&P 500: up 7.5% | TLSA trailed the S&P 500 by 65.9 percentage points Trailed |
| 1Y | TLSA: down 66.3% S&P 500: up 8.2% | TLSA trailed the S&P 500 by 74.5 percentage points Trailed |
| Long term | ||
| 3Y | TLSA: down 5.6% S&P 500: up 68.6% −1.9% vs +19.0% a year | TLSA trailed the S&P 500 by 74.2 percentage points Trailed |
| 5Y | TLSA: down 59.7% S&P 500: up 56.4% −16.6% vs +9.4% a year | TLSA trailed the S&P 500 by 116.1 percentage points Trailed |
$10,000 invested in TLSA 5 years ago (Nov 5, 2021) would be worth about $4,029 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $15,645.
All-time high
$6.99
Closing high on . Now 91.1% below that record.
Split-adjusted daily closes since Nov 20, 2018.
Stock splits
2
Latest: 5-for-2 on . One share bought before the first split is 5 shares today.
Both splits
- 5-for-2
- 2-for-1
Valuation
About Tiziana Life Sciences Ltd
Tiziana Life Sciences is a clinical-stage biopharmaceutical company developing breakthrough therapies using transformational drug delivery technologies to enable alternative routes of immunotherapy. Tiziana’s innovative nasal, oral and inhalation approaches in development have the potential to provide an improvement in efficacy as well as safety and tolerability compared to intravenous (IV) delivery. Tiziana’s two lead candidates, intranasal foralumab, the only fully human anti-CD3 mAb, and milciclib, a pan-CDK inhibitor, have both demonstrated a favorable safety profile and clinical response in patients in studies to date. Tiziana’s technology for alternative routes of immunotherapy has been patented with several applications pending and is expected to allow for broad pipeline applications.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- United Kingdom
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
TLSA news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
TLSA stock FAQ
What is TLSA stock’s price today?
Tiziana Life Sciences (TLSA) traded at $0.62 at the close on , down $0.02 (2.76%) from the previous close of $0.64. Over the past 52 weeks it has traded between $0.57 and $1.90.
If you invested $1,000 in TLSA 5 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in TLSA on would be worth about $403 at the close on , a total return of −59.7%. The same $1,000 would be worth $337 if invested one year ago. Past performance doesn’t predict future returns.
Does TLSA pay a dividend?
Tiziana Life Sciences hasn’t paid a dividend in the last twelve months.
What is TLSA’s 52-week high and low?
Over the past 52 weeks TLSA has traded as low as $0.57 and as high as $1.90. At $0.62 at the close on , it is 67.3% below that high and 9.4% above the low.
What is TLSA’s all-time high?
TLSA’s highest closing price was $6.99 on , adjusted for stock splits. At $0.62 at the close on , it is 91.1% below that record.
Has TLSA stock ever split?
Yes, twice: 2-for-1 on ; 5-for-2 on . One share bought before the first split would be 5 shares today.
How has TLSA stock performed?
Including dividends and measured to the close on , TLSA has returned −58.4% so far this year and −66.3% over the past year, and −59.7% over five years (−16.6% a year). Over the same periods the S&P 500, measured by SPY, returned +8.3%, +9.3% and +67.3%. Past performance doesn’t predict future returns.
What sector and industry is Tiziana Life Sciences in?
Tiziana Life Sciences is in the Healthcare sector and the Biotechnology industry, and is headquartered in United Kingdom.
What exchange does TLSA trade on?
Tiziana Life Sciences trades on the Nasdaq under the ticker symbol TLSA. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.